1. Home
  2. MTH vs KRYS Comparison

MTH vs KRYS Comparison

Compare MTH & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTH
  • KRYS
  • Stock Information
  • Founded
  • MTH 1985
  • KRYS 2015
  • Country
  • MTH United States
  • KRYS United States
  • Employees
  • MTH N/A
  • KRYS N/A
  • Industry
  • MTH Homebuilding
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MTH Consumer Discretionary
  • KRYS Health Care
  • Exchange
  • MTH Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • MTH 5.1B
  • KRYS 4.7B
  • IPO Year
  • MTH 1988
  • KRYS 2017
  • Fundamental
  • Price
  • MTH $69.32
  • KRYS $182.55
  • Analyst Decision
  • MTH Buy
  • KRYS Strong Buy
  • Analyst Count
  • MTH 9
  • KRYS 9
  • Target Price
  • MTH $85.00
  • KRYS $203.22
  • AVG Volume (30 Days)
  • MTH 805.4K
  • KRYS 372.8K
  • Earning Date
  • MTH 10-28-2025
  • KRYS 11-03-2025
  • Dividend Yield
  • MTH 2.38%
  • KRYS N/A
  • EPS Growth
  • MTH N/A
  • KRYS 36.22
  • EPS
  • MTH 8.78
  • KRYS 4.91
  • Revenue
  • MTH $6,216,250,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • MTH N/A
  • KRYS $34.33
  • Revenue Next Year
  • MTH $6.59
  • KRYS $47.84
  • P/E Ratio
  • MTH $8.22
  • KRYS $37.31
  • Revenue Growth
  • MTH N/A
  • KRYS 116.08
  • 52 Week Low
  • MTH $59.27
  • KRYS $122.80
  • 52 Week High
  • MTH $102.91
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • MTH 35.19
  • KRYS 74.86
  • Support Level
  • MTH $71.27
  • KRYS $158.08
  • Resistance Level
  • MTH $75.48
  • KRYS $186.75
  • Average True Range (ATR)
  • MTH 2.02
  • KRYS 6.03
  • MACD
  • MTH -0.42
  • KRYS 1.57
  • Stochastic Oscillator
  • MTH 1.87
  • KRYS 87.73

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: